Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 537

Results For "LA"

8967 News Found

Moderna posts Q4 2023 revenue at US$ 2.8 billion
News | February 23, 2024

Moderna posts Q4 2023 revenue at US$ 2.8 billion

Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance


AstraZeneca completes acquisition of Gracell
News | February 23, 2024

AstraZeneca completes acquisition of Gracell

The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F


Aptar Digital Health acquires Healint to broaden neurology portfolio
News | February 23, 2024

Aptar Digital Health acquires Healint to broaden neurology portfolio

The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment


Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students
Policy | February 22, 2024

Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students

We are achieving the target of developed India by making our young children healthy today


Pfizer and AIF’s Project Parivartan demonstrates progress in addressing antimicrobial resistance
News | February 22, 2024

Pfizer and AIF’s Project Parivartan demonstrates progress in addressing antimicrobial resistance

Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms


PM Modi inaugurates AIIMS Jammu
News | February 21, 2024

PM Modi inaugurates AIIMS Jammu

The fast pace of construction of AIIMS Jammu whose foundation stone laying to inauguration took only 5 years highlights the commitment of the Government


AstraZeneca completes acquisition of Icosavax
News | February 21, 2024

AstraZeneca completes acquisition of Icosavax

The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus


Scandron receives India's first logistics drone type-certification from DGCA
Supply Chain | February 20, 2024

Scandron receives India's first logistics drone type-certification from DGCA

The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions


European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis
Drug Approval | February 20, 2024

European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis

VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU


Biocon included in S&P Global Sustainability Yearbook 2024
Sustainability | February 20, 2024

Biocon included in S&P Global Sustainability Yearbook 2024

Sustainability is integral to Biocon's business purpose